Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | |
|---|---|---|
May 31, 2021 |
May 31, 2020 |
|
| Research and development expenses | $ 8,637,905 | $ 1,480,588 |
| Stock Options | ||
| Antidilutive securities | 1,587,081 | 1,587,081 |
| Restricted Stock Units | ||
| Antidilutive securities | 4,149,125 | 4,293,407 |
| Warrants | ||
| Antidilutive securities | 4,133,720 | 5,084,331 |